COVID vaccine patents accord between rich, developing nations possible in weeks: WTO
New Delhi: An accord between rich nations and developing countries on intellectual property waivers for Covid-19 vaccines could be just weeks away, the head of the World Trade Organization said Friday.
Developing countries that are lagging behind in vaccinating their populations have been pushing for waivers on the patents, or intellectual property rights, on Covid-19 vaccines as they say this would help spur local production.
That has pitted them against a group of mostly developed countries, including prominently EU nations, which believe that would discourage innovation and that other steps can be taken to boost access to vaccines.
"We hope that within the next few weeks we can have a breakthrough" on what has been a bone of contention for months, WTO leader Ngozi Okonjo-Iweala told a press conference.
"We believe there could be a sensible landing zone, a sensible compromise solution that would allow developing countries more access to technology transfer and IP whilst protecting innovation and research, not discouraging it," she added.
While a deal could be reached soon, it may not happen before the EU-African Union summit on February 17-18 in Brussels, said Okonjo-Iweala.
Addressing the same conference in Paris, French minister for foreign trade Franck Riester, said "what is important is access to vaccines."
This can be improved by lifting as far as possible restrictions to their distribution, he said.
"Intellectual property must never be a brake (on access) in developing countries," he added.
With France having this month taken over the rotating EU presidency Riester said if greater facilitation of distribution was required then the EU was "ready to do that in the most constructive possible manner."
Our comments section is governed by our Comments Policy . By posting comments at Medical Dialogues you automatically agree with our Comments Policy , Terms And Conditions and Privacy Policy .
Disclaimer: This website is primarily for healthcare professionals. The content here does not replace medical advice and should not be used as medical, diagnostic, endorsement, treatment, or prescription advice. Medical science evolves rapidly, and we strive to keep our information current. If you find any discrepancies, please contact us at corrections@medicaldialogues.in. Read our Correction Policy here. Nothing here should be used as a substitute for medical advice, diagnosis, or treatment. We do not endorse any healthcare advice that contradicts a physician's guidance. Use of this site is subject to our Terms of Use, Privacy Policy, and Advertisement Policy. For more details, read our Full Disclaimer here.
NOTE: Join us in combating medical misinformation. If you encounter a questionable health, medical, or medical education claim, email us at factcheck@medicaldialogues.in for evaluation.